These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 13756462)

  • 1. Potential uses of chelation methods in the treatment of cardiovascular diseases.
    KITCHELL JR; MELTZER LE; SEVEN MJ
    Prog Cardiovasc Dis; 1961 Jan; 3():338-49. PubMed ID: 13756462
    [No Abstract]   [Full Text] [Related]  

  • 2. [Introductory recollections on cellular and extracellular ionic balance, and changes brought about by chelating substances; preliminary notes on the use and the indications of said substances in cardiovascular pathology].
    MACCARINI PA
    Clin Ter; 1962 Jan; 22():126-32. PubMed ID: 14467754
    [No Abstract]   [Full Text] [Related]  

  • 3. Chelation therapy in atherosclerosis.
    OLWIN JH; KOPPEL JL
    Ill Med J; 1962 Sep; 122():292-4. PubMed ID: 14481976
    [No Abstract]   [Full Text] [Related]  

  • 4. EDTA chelation therapy for cardiovascular disease: a systematic review.
    Seely DM; Wu P; Mills EJ
    BMC Cardiovasc Disord; 2005 Nov; 5():32. PubMed ID: 16262904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chelating agents in the prevention and treatment of occupational diseases.
    BRIEGER H
    Arch Environ Health; 1960 Sep; 1():271-7. PubMed ID: 13804399
    [No Abstract]   [Full Text] [Related]  

  • 6. Chelation therapy in the treatment of cardiovascular diseases.
    Ibad A; Khalid R; Thompson PD
    J Clin Lipidol; 2016; 10(1):58-62. PubMed ID: 26892121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The action of chelating agents in Wilson's disease.
    HILL L; WALSHE JM
    Lancet; 1959 Sep; 2(7100):444-5. PubMed ID: 13852382
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronic Toxic Metal Exposure and Cardiovascular Disease: Mechanisms of Risk and Emerging Role of Chelation Therapy.
    Aneni EC; Escolar E; Lamas GA
    Curr Atheroscler Rep; 2016 Dec; 18(12):81. PubMed ID: 27822681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oral use of chelating agents in the treatment and prevention of lead poisoning].
    TOLOT F; JAQUIS ; GENEVOIS M; SOUBRIER R; BRESSON JR
    Arch Mal Prof; 1962 Jun; 23():376-9. PubMed ID: 13921666
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chelating agents in occupational pathology].
    MICHAUX P
    Alger Medicale; 1961 Oct; 65():789-802. PubMed ID: 14473389
    [No Abstract]   [Full Text] [Related]  

  • 11. Chelation therapy for cardiovascular disease. Review and commentary.
    Lewin MR
    Tex Heart Inst J; 1997; 24(2):81-9. PubMed ID: 9205980
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of chelating agents in treatment of metal poisoning (with special emphasis on lead).
    FOREMAN H
    Fed Proc; 1961 Sep; 20(3)Pt 2():191-6. PubMed ID: 13894041
    [No Abstract]   [Full Text] [Related]  

  • 13. EDTA Chelation Therapy to Reduce Cardiovascular Events in Persons with Diabetes.
    Ouyang P; Gottlieb SH; Culotta VL; Navas-Acien A
    Curr Cardiol Rep; 2015 Nov; 17(11):96. PubMed ID: 26364188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment with the chelating agent, dithizone, in thallium poisoning].
    ASTOLFI E
    Arch Argent Pediatr; 1961 Jul; 56():38-42. PubMed ID: 13862998
    [No Abstract]   [Full Text] [Related]  

  • 15. [The therapeutic possibilities of various chelating substances in radiation sickness].
    GALLI G
    Minerva Fisioter Radiobiol; 1959; 4():322-7. PubMed ID: 13826127
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of EDTA chelation therapy in cardiovascular diseases.
    Shrihari JS; Roy A; Prabhakaran D; Reddy KS
    Natl Med J India; 2006; 19(1):24-6. PubMed ID: 16570682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trace minerals, chelating agents and the porphyrias.
    PETERS HA
    Fed Proc; 1961 Sep; 20(3)Pt 2():227-34. PubMed ID: 14485735
    [No Abstract]   [Full Text] [Related]  

  • 18. Chelation therapy in cardiovascular disease: an update.
    Sultan S; Murarka S; Jahangir A; Mookadam F; Tajik AJ; Jahangir A
    Expert Rev Clin Pharmacol; 2017 Aug; 10(8):843-854. PubMed ID: 28597699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of chelates for therapeutic objectives.
    RUBIN M
    Fed Proc; 1961 Sep; 20(3)Pt 2():149-56. PubMed ID: 14494918
    [No Abstract]   [Full Text] [Related]  

  • 20. [Observations on the use of sodium diethyldithiocarbamate in therapy].
    PARMEGGIANI L; PALLENI R
    Med Lav; 1961 May; 52():377-81. PubMed ID: 14483977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.